Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 14, 2026, 2:31 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1489–1512 of 1,825 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Media Clear all

Conditions: Obesity, Diabetes Mellitus, Type 2, Appetitive Behavior
Interventions: Pearl millet couscous - made in Senegal, Pearl millet couscous - made in USA, Pearl millet thick porridge, Wheat couscous, White rice; Other
Lead sponsor: Purdue University; Other
Eligibility: 18 Years to 50 Years
Enrollment: 15 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018
U.S. locations: 1
States / cities: West Lafayette, Indiana

Conditions: Obesity, Diabetes
Interventions: TSSC, TSSC Randomized Behavioral Intervention for weight loss; Behavioral
Lead sponsor: The University of Texas Health Science Center, Houston; Other
Eligibility: 18 Years to 75 Years
Enrollment: 3,100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2003 – 2013
U.S. locations: 1
States / cities: Brownsville, Texas

Conditions: Blood Glucose, GLP-1, Satiety, Second Meal Intake, Healthy Participant Study
Interventions: Maltodextrin (Placebo), Raw Corn Starch; Dietary Supplement
Lead sponsor: Purdue University; Other
Eligibility: 18 Years to 45 Years
Enrollment: 17 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026
U.S. locations: 1
States / cities: West Lafayette, Indiana

Conditions: Acute Otitis Media, Otitis Media, Ear Infection
Interventions: Montelukast, Placebo; Drug
Lead sponsor: Deborah Gentile; Other
Eligibility: 18 Months to 5 Years
Enrollment: 99 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2005
U.S. locations: 2
States / cities: Bellevue, Pennsylvania • Pittsburgh, Pennsylvania

Conditions: Substance Use Disorders, Parenting
Interventions: PURPOSE; Behavioral
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 21 Years and older
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Chemical Peel
Interventions: Aquaphor, HP828-101; Drug
Lead sponsor: Healthpoint; Industry
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Post-Traumatic Stress Disorder F03.950.750.500 D013313
Interventions: Art-therapy Remote Treatment for Veterans Experiencing Trauma; Behavioral
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years to 55 Years
Enrollment: 84 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027 – 2030
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: Lung Cancer
Interventions: LungTalk, Non-tailored intervention - Standard of practice; Behavioral
Lead sponsor: Hackensack Meridian Health; Other
Eligibility: 50 Years to 80 Years
Enrollment: 512 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Nutley, New Jersey

Conditions: Smoking Cessation
Interventions: Recommender CTHC, Standard CTHC, Peer Recruitment, Standard Online Recruitment; Behavioral · Other
Lead sponsor: University of Massachusetts, Worcester; Other
Eligibility: 18 Years and older
Enrollment: 1,487 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2020
U.S. locations: 1
States / cities: Worcester, Massachusetts

Conditions: Otitis Media With Effusion
Interventions: bilateral myringotomy, bilateral myringotomy and tubes, adenoidectomy; Procedure
Lead sponsor: National Institute on Deafness and Other Communication Disorders (NIDCD); NIH
Eligibility: 24 Months to 47 Months
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1997 – 2007
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Healthy
Interventions: Ketamine, Ts-134 or XT, Placebo; Drug
Lead sponsor: New York State Psychiatric Institute; Other
Eligibility: 18 Years to 55 Years
Enrollment: 120 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2029
U.S. locations: 1
States / cities: New York, New York

Conditions: Adolescent
Interventions: Ho'ouna Pono; Behavioral
Lead sponsor: Judge Baker Children's Center; Other
Eligibility: 11 Years to 13 Years
Enrollment: 130 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2030
U.S. locations: 2
States / cities: Kaneohe, Hawaii • Boston, Massachusetts

Conditions: Complication of Hemodialysis
Interventions: Dialysate and serum sodium concentration aligned; Other
Lead sponsor: Renal Research Institute; Other
Eligibility: 18 Years to 88 Years
Enrollment: 148 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2014
U.S. locations: 1
States / cities: New York, New York

Conditions: Respiratory Syncytial Virus Infections
Interventions: RSV Vaccine (GSK3844766A) unadjuvanted low dose, RSV Vaccine (GSK3844766A) low dose adjuvanted with AS01E, RSV Vaccine (GSK3844766A) low dose adjuvanted with AS01B, RSV Vaccine (GSK3844766A) unadjuvanted medium dose, RSV Vaccine (GSK3844766A) medium dose adjuvanted with AS01E, RSV Vaccine (GSK3844766A) medium dose adjuvanted with AS01B, RSV Vaccine (GSK3844766A) unadjuvanted high dose, RSV Vaccine (GSK3844766A) high dose adjuvanted with AS01E, RSV Vaccine (GSK3844766A) high dose adjuvanted with AS01B, Placebo (Saline solution); Biological · Drug
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 1,053 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2020
U.S. locations: 18
States / cities: Jacksonville, Florida • Miami, Florida • Stockbridge, Georgia + 15 more

Conditions: Influenza Immunization, Healthy Volunteers
Interventions: mRNA NA vaccine, High Dose Quadrivalent Influenza Vaccine; Biological
Lead sponsor: Sanofi Pasteur, a Sanofi Company; Industry
Eligibility: 18 Years and older
Enrollment: 233 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2024
U.S. locations: 6
States / cities: Huntsville, Alabama • Phoenix, Arizona • San Diego, California + 3 more

Conditions: Social Media Literacy
Interventions: interactive website; Other
Lead sponsor: Boston University; Other
Eligibility: 18 Years and older
Enrollment: 120 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2027
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Infertility
Interventions: Vitrification medium oocyte, warming medium oocyte and Rapid-i; Device
Lead sponsor: Vitrolife; Industry
Eligibility: 18 Years to 37 Years · Female only
Enrollment: 17 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012
U.S. locations: 2
States / cities: Dallas, Texas • Frisco, Texas

Conditions: Otitis Media
Interventions: Not listed
Lead sponsor: University of Pittsburgh; Other
Eligibility: 3 Years to 3 Years
Enrollment: 126 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006 – 2018
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Type 1 Diabetes
Interventions: Social Media; Behavioral
Lead sponsor: Seattle Children's Hospital; Other
Eligibility: 13 Years to 18 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Seattle, Washington

Conditions: Distress, Emotional, Suicide
Interventions: Peer support intervention; Behavioral
Lead sponsor: Harvard University; Other
Eligibility: 18 Years and older
Enrollment: 942 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Uterine Cervical Neoplasms, Uterine Neoplasms, Ovarian Neoplasms, Urogenital Neoplasms, Fallopian Tube Neoplasms
Interventions: Guided Imagery With Audio Media; Behavioral
Lead sponsor: University of Michigan; Other
Eligibility: 18 Years and older · Female only
Enrollment: 130 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Patients Undergoing Thoracic Surgery, Patients Undergoing Upper Abdominal Surgery
Interventions: Fluoroscopic imaging; Procedure
Lead sponsor: Chicago Anesthesia Pain Specialists; Other
Eligibility: 18 Years to 80 Years
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2018
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Clostridium Infections
Interventions: Vaccine diluent buffer (Placebo), C. difficile toxoid vaccine (2 µg), C. difficile toxoid vaccine (10 µg), C. difficile toxoid vaccine (50 µg); Biological
Lead sponsor: Sanofi; Industry
Eligibility: 65 Years and older
Enrollment: 48 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2005 – 2006
U.S. locations: 2
States / cities: Orlando, Florida • Lexington, Kentucky

Conditions: Cannabis, Low Back Pain, Neuropathic Pain
Interventions: Placebos, dronabinol, Vaporized Cannabis 3.7% THC/5.6% CBD; Drug
Lead sponsor: University of California, San Diego; Other
Eligibility: 19 Years to 70 Years
Enrollment: 131 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2020
U.S. locations: 1
States / cities: San Diego, California

Search by objective public record fields.

Digestive Properties of Carbohydrate-based Foods

Tu Salud Si Cuenta Media Campaign

Slowly Digestible Carbohydrates for GLP-1 Secretion

A Pilot Study to Evaluate the Efficacy of Montelukast in the Treatment of Acute Otitis Media (AOM) in Children

PURPOSE: A Social Media Intervention for Parent Support

Post Treatment Care After Chemical Peel or Laser Resurfacing

Creative Art Teletherapy for Veterans With PTSD

The INSPIRE-Lung Study

Smoker-to-Smoker (S2S) Peer Marketing and Messaging to Disseminate Tobacco Interventions

Adenoidectomy for Otitis Media in 2-3 Year Old Children

Glutamatergic Mechanisms: Aim2

Mohala Na Pua: Community-driven Drug Prevention

Effects of Simple Sodium Alignment on Clinical Outcomes

A Study to Assess the Safety, Reactogenicity and Immune Response of GlaxoSmithKline (GSK) Biologicals' Investigational Respiratory Syncytial Virus (RSV) Vaccine (GSK3844766A) in Older Adults

Study to Assess the Safety and Immunogenicity of Monovalent mRNA NA Vaccine in Adult Participants 18 Years of Age and Older

The Interactive Media and Gender-related Stressors and Strengths Study

Performance Study of New Media for Vitrification of Human Oocytes

Eustachian Tube Growth and Development

Social Media Use in Adolescent Diabetes Care

Brief Interventions on Social Media to Reduce Suicide Risk (Intervention 1)

Guided Imagery in the Perioperative Period in Gynecologic Oncology Patients

Accuracy of the Thoracic Epidural Catheter Insertion Confirmed by Fluoroscopic Imaging

Safety, Tolerability, and Immunogenicity of a Clostridium Difficile Toxoid Vaccine in Healthy Elderly Volunteers

Trial of Dronabinol and Vaporized Cannabis in Chronic Low Back Pain